K Pharma

4896.TTSE GROWTHPharmaceutical
Filed as K Pharma, Inc. (2023-11–2026-08)
Major holders (5%+) · 2
HolderStakeChangeFiled
SBI Ventures Two Co., Ltd.14.88%0.00pp2025-04-04
Hideyuki Okano10.03%-1.02pp2026-04-13

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 3
ITOCHU Technology Ventures, Inc.2.02%2025-03-31
SBI SECURITIES Co., Ltd.0.22%2025-04-04
SBI Investment Co., Ltd.0.00%2025-04-04
Ownership history · 13
FiledHolderRatioChangePurpose
2026-04-13Hideyuki Okano2026-04-1310.03%-1.02ppStable shareholder; Long-term holding
2025-05-02Hideyuki Okano2025-05-0211.05%newStable shareholder; Long-term holding
2025-04-04AmendedSBI Investment Co., Ltd.2025-04-04 · amended0.00%-1.98pp—
2025-04-04AmendedSBI SECURITIES Co., Ltd.2025-04-04 · amended0.22%no changeSecurities trading business
2025-04-04AmendedSBI Ventures Two Co., Ltd.2025-04-04 · amended14.88%no changePure investment
2025-04-03AmendedSBI SECURITIES Co., Ltd.2025-04-03 · amended0.22%no changeSecurities trading business
2025-04-03AmendedSBI Investment Co., Ltd.2025-04-03 · amended1.98%-2.07ppPure investment
2025-04-03AmendedSBI Ventures Two Co., Ltd.2025-04-03 · amended14.88%no changePure investment
2025-04-02AmendedSBI SECURITIES Co., Ltd.2025-04-02 · amended0.22%newSecurities trading business
2025-04-02AmendedSBI Investment Co., Ltd.2025-04-02 · amended4.05%newPure investment
2025-04-02AmendedSBI Ventures Two Co., Ltd.2025-04-02 · amended14.88%newPure investment
2025-03-31ITOCHU Technology Ventures, Inc.2025-03-312.02%-3.11ppPure investment
2024-06-19AmendedITOCHU Technology Ventures, Inc.2024-06-19 · amended5.13%newPure investment

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.